Emmis Acquisition Corp. (EMIS) Stock Price & Analysis
Emmis Acquisition Corp. (EMIS) rose 0.00% to USD 10.15 as of June 10, 2026 at 03:37 UTC, according to Nexqual real-time market data.
EMIS last closed at USD 10.15; the session ranged USD 10.15–10.15 on volume of 0 shares. Market capitalization is $160.12M, with a 52-week range of USD 9.9–10.15 (NGM). Source: Nexqual, June 10, 2026 at 03:37 UTC.
Key Statistics (as of June 10, 2026 at 03:37 UTC)
| Price | USD 10.15 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.15 |
| Open | USD 0 |
| Day Range | USD 10.15 – 10.15 |
| 52-Week Range | USD 9.9 – 10.15 |
| Volume | 0 shares |
| Market Cap | $160.12M |
| Exchange | NGM |
Technical Analysis (EMIS)
Nexqual's technical model rates EMIS "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 03:37 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 65.07 (neutral) |
| vs SMA50 | Above (USD 10.09) |
| MACD | 0.01 (positive) |
Analyst Ratings (EMIS)
Wall Street analysts rate EMIS "None", per Nexqual as of June 10, 2026 at 03:37 UTC.
| Consensus Rating | None |
|---|
Earnings (EMIS)
Source: Nexqual, June 10, 2026 at 03:37 UTC.
Financials & Fundamentals (EMIS)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 11.76 |
| Total Cash | $782,141 |
| Total Debt | $0 |
Source: Nexqual, June 10, 2026 at 03:37 UTC.
Financial Health Score (EMIS)
Nexqual rates Emmis Acquisition Corp.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:37 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $782K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$602K |
| Efficiency | Mixed — No data |
Ownership (EMIS)
| Insider Ownership | +13.33% |
|---|---|
| Institutional Ownership | +92.55% |
| Shares Outstanding | 11.94M |
| Float | 10.84M |
| Short % of Float | +0.08% |
Source: Nexqual, June 10, 2026 at 03:37 UTC.
Leadership (EMIS)
Emmis Acquisition Corp. is led by Peter Joseph Goldstein (age 62), Chairman & CEO, per Nexqual as of June 10, 2026 at 03:37 UTC.
| Chairman & CEO | Peter Joseph Goldstein (age 62) |
|---|---|
| CFO & Director | David Lowenstein (age 62) |
Major Backers & Investors (EMIS)
Notable institutional backers of Emmis Acquisition Corp. include Karpus Management, Inc., Glazer Capital LLC, Linden Advisors LP, according to Nexqual as of June 10, 2026 at 03:37 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Karpus Management, Inc. | 25.6% |
| Glazer Capital LLC | 20.38% |
| Linden Advisors LP | 19.57% |
| Shaw D.E. & Co., Inc. | 14.83% |
| Aristeia Capital, LLC | 14.62% |
| Mint Tower Capital Management B.V. | 13.04% |
| Mangrove Partners IM, LLC | 13.04% |
| Radcliffe Capital Management, L.P. | 13.02% |
Source: Nexqual, June 10, 2026 at 03:37 UTC.
From Emmis Acquisition Corp.'s Latest SEC 10-K Filing (filed 2026-03-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Previously, she was the venture capital and startups lead at Amazon Web Services from January 2020 to October 2023 and the Pre-VC startups and ecosystem lead there from January 2020 to August 2023.
- We believe this focus will allow us to leverage the industry knowledge, operational expertise, and extensive networks of our officers, directors, and affiliates of our sponsor.
- Because we are able to complete our initial business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business to fit its needs and desires.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CASIF | CASI Pharmaceuticals, Inc. | USD 0.1 | ▼ 21.54% |
| ATRX | Adhera Therapeutics Inc. | USD 0 | ▲ 0% |
| CVAS | CREATIVE VISTAS INC | USD 0 | ▲ 0% |
| GNTA | Genenta Science S.p.A. | USD 1.6 | ▼ 21.57% |
| ALKS | Alkermes plc | USD 44.29 | ▲ 3.48% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:37 UTC. This page is informational and not investment advice.